Showing 1781-1790 of 9289 results for "".
Save Big Bucks by Using Vendor-Sponsored Customer Loyalty Programs
https://practicaldermatology.com/topics/practice-management/save-big-bucks-by-using-vendor-sponsored-customer-loyalty-programs/21223/Vendors invest millions of dollars in sophisticated direct-to-consumer loyalty campaigns designed to drive traffic to the practices they serve. Smart practices use these programs to their advantage to reward, recruit, retain, and convert patients.Recently Passed Law Clears Way for New Sunscreen Ingredients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recently-passed-law-clears-way-for-new-sunscreen-ingredients/21232/By forcing the FDA to clear its backlog of sunscreen ingredients pending review, The Sunscreen Innovation Act is a major win for UV protection efforts.Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.Strategic Situations
https://practicaldermatology.com/topics/practice-management/strategic-situations/21303/Should you consider adding a patient care coordinator?Converting Telephone Inquiries into New Patients Through Mystery Shopping
https://practicaldermatology.com/topics/practice-management/converting-telephone-inquiries-into-new-patients-through-mystery-shopping/21371/Tips to help practices convert calls into appointments.Employee Engagement: A Key Success Factor in the Workplace
https://practicaldermatology.com/topics/practice-management/employee-engagement-a-key-success-factor-in-the-workplace/21387/Tips for increasing productivity and satisfaction among staff.The Melanoma Pipeline
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-melanoma-pipeline/21400/A closer look at the latest data for two investigational agents that have made headlines.Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.A State of Transition for EHRs
https://practicaldermatology.com/topics/practice-management/a-state-of-transition-for-ehrs/22953/As practitioners await the next step in the larger implementation of this technology, an emphasis on utility is more important than ever.Content is the New Focal Point of Your SEO Strategy
https://practicaldermatology.com/topics/practice-management/content-is-the-new-focal-point-of-your-seo-strategy/22941/The goal of your dermatology website is to disseminate original, relevant and useful information that addresses readers' queries in a most satisfying manner.